Tempest Therapeutics, Inc. (TPST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 250K 500K 750K FY13: 0 FY14: 0 FY15: 277K FY16: 653K FY17: 295K FY13 FY14 FY15 FY16 FY17

Gross Profit Annual

-6M -4M -2M 0 2M 4M 6M FY13: 0 FY14: 0 FY15: -2M FY16: -4.7M FY17: -495K FY13 FY14 FY15 FY16 FY17

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY21: -27M FY22: -34.6M FY23: -29.2M FY24: -42M FY25: -26.6M FY21 FY22 FY23 FY24 FY25

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY21: -28.3M FY22: -35.7M FY23: -29.5M FY24: -41.8M FY25: -26.3M FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 2M 4M 6M FY13: 0 FY14: 0 FY15: 2.2M FY16: 5.4M FY17: 790K FY13 FY14 FY15 FY16 FY17

Operating Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY21: -26M FY22: -31.1M FY23: -27.4M FY24: -33M FY25: -26.8M FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY21: -26.1M FY22: -31.6M FY23: -27.5M FY24: -33.5M FY25: -26.8M FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 6M 12M 18M FY21: 3.8M FY22: 11.5M FY23: 15.4M FY24: 2.1M FY25: 4.1M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-45.00 -30.00 -15.00 0.00 15.00 30.00 45.00 Q3 '21: -37.13 Q4 '21: -7.47 Q1 '22: 1.90 Q2 '22: 8.74 Q3 '22: 9.29 Q4 '22: -3.26 Q1 '23: -2.63 Q2 '23: -2.38 Q3 '23: -2.20 Q4 '23: -1.91 Q1 '24: -5.98 Q2 '24: -10.96 Q3 '24: -15.80 Q4 '24: -19.48 Q1 '25: -18.02 Q2 '25: -14.57 Q3 '25: -10.04 Q4 '25: -6.64 Q1 '26: -6.01 Q2 '26: -4.28 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.